Similarly, in the amyloid precursor protein/presenilin (APP/PS1) double and APP/PS1/Tau triple transgenic mouse models of AD, liraglutide treatment attenuates spatial memory impairments (McClean et al., 2011; Chen et al., 2017). This evidence concerns the gene APP and Alzheimer disease.